A RANDOMIZED, NON-INFERIORITY STUDY COMPARING EFFICACY AND SAFETY OF A SINGLE DOSE OF PEGFILGRASTIM VERSUS DAILY FILGRASTIM IN PEDIATRIC PATIENTS AFTER AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANT.

A randomized, non-inferiority study comparing efficacy and safety of a single dose of pegfilgrastim versus daily filgrastim in pediatric patients after autologous peripheral blood stem cell transplant.

PurposeTo assess the non-inferiority of pegfilgrastim versus filgrastim in speeding the recovery of polymorphonuclear cells (PMN) in pediatric patients who underwent autologous peripheral blood stem cell transplant (PBSCT).MethodsThe sample size of this randomized, multicenter, phase III study, was calculated assuming that a single dose of pegfilgr

read more


Live attenuated-nonpathogenic Leishmania and DNA structures as promising vaccine platforms against leishmaniasis: innovations can make waves

Leishmaniasis is a vector-borne disease caused by the protozoan parasite of Leishmania genus and is a complex disease affecting mostly tropical regions of the world.Unfortunately, despite the extensive effort made, there is no vaccine available for human use.Undoubtedly, a comprehensive understanding of the host-vector-parasite interaction is subst

read more